This treatment helps to strengthen and nourish, resulting in improved texture and shine
GSTs, primarily GSTA1-1, are involved in the first step of the metabolic pathway of busulfan 79,80
Motor neuron disease associated with copper deficiency
Rescue therapy was needed by 8%, 25%, and 67%, respectively. Five milligrams preserved most, but not all, of the benefit of continuing the effective dose
Tranexamic acid (topical): Investigated in clinical trials for melasma with more robust evidence than IV glutathione
This produces a concentration of approximately 16.7 mg/mL